Local Targeted Therapy of Liver Metastasis from Colon Cancer by   Galactosylated Liposome Encapsulated with Doxorubicin

doi:10.1371/journal.pone.0073860

CORC > 北京大学 > 化学与分子工程学院

	Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin
	Zhao, Chen ; Feng, Qiang ; Dou, Zengpei ; Yuan, Wei ; Sui, Chenguang ; Zhang, Xinghua ; Xia, Guimin ; Sun, Hongfang ; Ma, Jie
刊名	plos one
	2013
关键词	UNRESECTABLE HEPATOCELLULAR-CARCINOMA COLORECTAL-CANCER IN-VIVO ASIALOGLYCOPROTEIN RECEPTOR GASTRIC-CARCINOMA GENE DELIVERY PHASE-II DRUG SIZE BIODISTRIBUTION
DOI	10.1371/journal.pone.0073860
英文摘要	Since regional drug administration enables to maintain a high drug concentration within tumors, we compared the plasma concentration and biodistribution of doxorubicin (Dox) from drug-loaded conventional liposomes by local or systemic administration. The results demonstrated that drug concentration was substantially improved in liver as well as a decrease in blood and other organs by spleen injection mimicking portal vein perfusion (regional administration). To further investigate the targeted therapeutic effect of galactosylated liposome encapsulated doxorubicin (Dox) by regional administration, liver targeting liposomes were prepared by incorporating galactosylated-DPPE to conventional liposomes. Liposome uptake and targeting were verified in vitro and in vivo by fluorescence microscopy and xenogen IVIS imaging system, respectively. The results showed that galactose targeted liposomes presented a stronger specific cell uptake by human hepatocellular carcinoma HepG2 cells compared to the non-targeted liposomes. In vivo fluorescence imaging showed that the intra-hepatic deposition of conventional and galactosylated liposomes via spleen injection was more than that via tail vein administration, and galactosylated liposomes had higher fluorescent intensity over conventional liposomes in the liver post spleen administration. The anti-tumor effect of various drug administration routes for both liposomal formulations was evaluated using a murine liver metastasis model of colon cancer. The results indicated that tumor progression in the liver and mesenteric lymph nodes was significantly suppressed by Dox-loaded galactosylated liposomes via spleen injection, while no significance was observed in non-targeted formulations. Our data indicated that local perfusion of galactosylated liposomal doxorubicin had a great promise for the treatment of liver metastasis from colon cancer.; Multidisciplinary Sciences; SCI(E); 2; ARTICLE; 9; 8
语种	英语
内容类型	期刊论文
源URL	[http://ir.pku.edu.cn/handle/20.500.11897/391045]
专题	化学与分子工程学院
推荐引用方式 GB/T 7714	Zhao, Chen,Feng, Qiang,Dou, Zengpei,et al. Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin[J]. plos one,2013.
APA	Zhao, Chen.,Feng, Qiang.,Dou, Zengpei.,Yuan, Wei.,Sui, Chenguang.,...&Ma, Jie.(2013).Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin.plos one.
MLA	Zhao, Chen,et al."Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin".plos one (2013).